Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
Author:
Funder
Konkuk University
Publisher
Elsevier BV
Reference24 articles.
1. Targeting CD38 with daratumumab monotherapy in multiple myeloma;Lokhorst;N. Engl. J. Med.,2015
2. The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases;Hogan;Front. Immunol.,2019
3. CD38: a new paradigm in lymphocyte activation and signal transduction;Lund;Immunol. Rev.,1998
4. CD38 as an immunotherapeutic target in multiple myeloma;Bonello;Expet Opin. Biol. Ther.,2018
5. CD38 is expressed on inflammatory cells of the intestine and promotes intestinal inflammation;Schneider;PloS One,2015
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Daratumumab and isatuximab differentially affect CD38 detection on plasma cells in myeloma: Anti‐CD38 nanobody (clone JK36) and CD319 combination improve flow cytometric identification of plasma cells after targeted therapies;British Journal of Haematology;2025-06-19
2. Impact of Human Genetic Variation Underlying Resistance to Antigen-Specific Immunotherapy;2025-05-07
3. Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects;Frontiers in Immunology;2025-02-12
4. Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity;mAbs;2025-01-30
5. CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma;2024-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3